JP2002275001A - Jellylike preventive material for humoral ooze and method for preventing humoral ooze using the same - Google Patents

Jellylike preventive material for humoral ooze and method for preventing humoral ooze using the same

Info

Publication number
JP2002275001A
JP2002275001A JP2001078131A JP2001078131A JP2002275001A JP 2002275001 A JP2002275001 A JP 2002275001A JP 2001078131 A JP2001078131 A JP 2001078131A JP 2001078131 A JP2001078131 A JP 2001078131A JP 2002275001 A JP2002275001 A JP 2002275001A
Authority
JP
Japan
Prior art keywords
jelly
body fluid
fluid leakage
preventing
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001078131A
Other languages
Japanese (ja)
Other versions
JP3586207B2 (en
Inventor
Tsukasa Nishihara
司 西原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18934785&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2002275001(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to JP2001078131A priority Critical patent/JP3586207B2/en
Publication of JP2002275001A publication Critical patent/JP2002275001A/en
Application granted granted Critical
Publication of JP3586207B2 publication Critical patent/JP3586207B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a preventive material for humoral ooze, capable of being smoothly injected into the coelom with a light force, absorbing the humors in the coelom and swelling so as to seal the coelom and to prevent the humoral ooze. SOLUTION: This preventive material for humoral ooze is a jellylike one dispersed and mixed with a powder, and the objective method for preventing the humoral ooze comprises using the preventive material for humoral ooze and loading the preventive material into the coelom.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、遺体からの体液漏
出を防止するために、遺体の体腔に装填される体液漏出
防止材及びその体液漏出防止材を使用した体液漏出防止
方法に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a body fluid leakage preventive material to be inserted into a body cavity of a corpse and a method of preventing body fluid leakage using the body fluid leakproof material in order to prevent body fluid leakage from the body. .

【0002】[0002]

【従来の技術】人体は、死亡後に胃液、肺液、腹水、排
泄物などの体液を漏出させることがある。このため、例
えば病院では、死亡確認後、遺体の口、鼻、耳、肛門、
女性の膣等の体腔にガーゼ、脱脂綿等を装填し、体液の
漏出を防ぐことが行なわれている。また、事故や手術後
の遺体の開口部にも同様な処置がとられている。
2. Description of the Related Art The human body may leak body fluids such as gastric juice, lung fluid, ascites and excrement after death. For this reason, for example, in hospitals, after confirming death, the mouth, nose, ears, anus,
2. Description of the Related Art Gauze, cotton wool, and the like are loaded into a body cavity such as a woman's vagina to prevent leakage of body fluid. Similar measures are taken at the opening of the corpse after an accident or surgery.

【0003】ガーゼ、脱脂綿等に代えて高吸水性の樹脂
粉末を口、鼻、耳、咽喉などに装填することが知られて
いる。例えば、特開平7−265367号公報では、安
定化二酸化塩素を含む吸水性樹脂粉末を咽喉には粉末の
まま、耳孔、鼻孔には水溶性シートに包んで使用するこ
とが知られている。また、特開平10−298001号
公報のように、注射器を使って口、鼻、耳に高吸水性樹
脂粉末を装填することが知られている。
It is known that a highly water-absorbent resin powder is loaded into the mouth, nose, ears, throat and the like in place of gauze, absorbent cotton and the like. For example, in Japanese Patent Application Laid-Open No. 7-26567, it is known that a water-absorbent resin powder containing stabilized chlorine dioxide is used as it is in the throat while being wrapped in a water-soluble sheet for the ear and nostrils. Also, as in Japanese Patent Application Laid-Open No. 10-298001, it is known that a mouth, a nose, and an ear are loaded with a superabsorbent resin powder using a syringe.

【0004】[0004]

【発明が解決しようとする課題】一般的に行なわれてい
る遺体の口、鼻、耳等の体腔にガーゼ、脱脂綿等を装填
する方法では、漏出体液が多い場合には、ガーゼ、脱脂
綿等では不十分であって、体外に漏れ出たりしている。
漏出した体液の処理時に病原菌に感染する恐れがあり、
作業者からは嫌われている。また新しいガーゼ、脱脂綿
等と交換する必要があり、煩わしいだけでなく、遺体体
液を介して病原菌が感染する危険性があり、交換時には
その周辺に漏出体液の悪臭が残るなどの問題がある。
According to the general method of loading gauze, cotton wool or the like into the body cavity such as the mouth, nose and ears of a corpse, if there are many leaked bodily fluids, gauze, cotton wool or the like is used. Inadequate and leaking out of the body.
When treating the leaked body fluid, there is a risk of infection with pathogenic bacteria,
Disliked by workers. In addition, it is necessary to replace with new gauze, absorbent cotton, or the like, which is not only troublesome, but also involves a risk of infecting with pathogenic bacteria through body fluids, and there is a problem that, at the time of replacement, a stench of the leaked body fluid remains around.

【0005】特開平7−265367号公報のように咽
喉部に高吸水性樹脂粉末を装填しようとしても、装填す
るための手段がなくては、狭い間隔の体腔例えば咽喉
部、肛門等では装填することが困難である。
[0005] Even if the throat is to be loaded with the superabsorbent resin powder as disclosed in Japanese Patent Application Laid-Open No. Hei 7-265367, there is no means for loading the powder in a body cavity at a narrow interval such as the throat or anus. It is difficult.

【0006】特開平10−298001号公報では、出
来るだけ流動性を確保するために、高吸収ポリマの微粉
末を使用することを述べている。しかし、鼻孔や耳孔の
入口部分に入れるのであれば、この公報のように微粉末
を注射器のようなシリンダで投入しても充填できるが、
奥までは充填できない。特に、奥まで充填するために、
急速にシリンダを動かすと、先端から出る微粉末が飛び
散るだけで、かえって遺体周辺を汚すだけである。
[0006] Japanese Patent Application Laid-Open No. 10-298001 describes that a fine powder of a high-absorbency polymer is used in order to ensure fluidity as much as possible. However, if it is put in the entrance of the nostrils or ear canal, it can be filled even if the fine powder is injected with a cylinder like a syringe as in this publication,
It cannot be filled to the back. In particular, to fill to the back,
When the cylinder is moved rapidly, the fine powder coming out of the tip just scatters, but only contaminates around the body.

【0007】即ち、特開平7−265367号公報や特
開平10−298001号公報のように粉末をそのまま
遺体に充填する方法では、粉末を押圧しても粉末自体の
密度が上がるだけで、充填器内をスムーズに流れないの
で、シリンダを使用しても充填することが困難である。
また、飛び出る粉末が拡散するので、粉末を固めて栓を
したい所に粉末を留めることが困難であり、場合によっ
ては、遺体外に出て遺体周辺を汚す恐れがある。さら
に、粉末をそのまま遺体に装填する場合には、体液の少
ない遺体に対しては微粉末がこぼれ出たり、又はゲルが
溶けて漏れ出る可能性がある。
That is, in the method of filling powder into a body as it is, as disclosed in Japanese Patent Application Laid-Open Nos. Hei 7-26567 and Hei 10-298001, even if the powder is pressed, only the density of the powder itself increases. Since it does not flow smoothly through the inside, it is difficult to fill even if a cylinder is used.
In addition, since the popping powder is diffused, it is difficult to solidify the powder and keep the powder at a place where a plug is desired, and in some cases, the powder may go out of the body and stain the area around the body. Furthermore, when the powder is directly loaded into the body, there is a possibility that the fine powder may spill out into the body with little body fluid, or the gel may melt and leak.

【0008】特に、粉末としては、体液を吸収して膨潤
することに主眼が置かれ、各種の樹脂粉末の開発が行な
われている。いずれも親水性樹脂粉末であり、この種の
樹脂粉末は体液を吸収して膨潤してゲル化する機能は優
れている。しかし、この種の樹脂粉末は吸収量が多いと
ゾル状になり、更に進むと溶けるものが多い。また、体
液が、胃酸などの強酸性体液や胆汁などのアルカリ性体
液を含んでいると、ゲル状態を維持できないものが多
い。
[0008] In particular, as a powder, various resin powders have been developed with an emphasis on absorbing body fluid and swelling. Both are hydrophilic resin powders, and this kind of resin powder has an excellent function of absorbing body fluid, swelling and gelling. However, this type of resin powder becomes a sol when the amount of absorption is large, and is often melted as it proceeds further. In addition, if the body fluid contains a strongly acidic body fluid such as gastric acid or an alkaline body fluid such as bile, the gel state cannot be maintained in many cases.

【0009】また、粉体でなく、ゼリーを用いるものと
して、特開平08−133901号公報のものが知られ
ている。この公報では、消臭剤入りの粉末ポリマーを適
当量の水で溶かし適当に混合してゼリーにし、遺体の鼻
腔の奥、口腔の奥、耳穴の奥に注入器等で圧入し充満さ
せ、ゼリーで止血し、その外側に更に衛生綿で栓をする
ものである。
Japanese Patent Application Laid-Open No. 08-133901 discloses a method using jelly instead of powder. In this gazette, a powdered polymer containing a deodorant is dissolved in an appropriate amount of water and mixed appropriately to form jelly. To stop the bleeding and plug the outside with sanitary cotton.

【0010】この公報のものでは、ゼリーに消臭剤を混
合して異臭を防止するようにし、ゼリー自体で栓をする
ことを狙いとしている。その上、ゼリーだけでは封止が
十分でないので、衛生綿等で更に封止するようにしてい
る。この公報のように、粉末ポリマーを水に溶かしてゼ
リー状にすれば、流動性が良くなるので、鼻孔等の奥に
も注入しやすく、注入器を使って注入しても、粉体のよ
うに飛散することも無く、注入管を伝って滑らかに注入
できる。しかし、既に水に溶かしているために、本来ポ
リマーが有する給水性能はほとんどなくなっている。し
たがって、ゼリーは鼻孔の隙間を埋める栓としての機能
でしか使われなく、鼻孔を十分に封止することができな
い。
In the publication, the jelly is mixed with a deodorant to prevent an unpleasant odor, and the jelly itself is plugged. In addition, since sealing is not sufficient with only jelly, further sealing is performed with sanitary cotton or the like. As described in this gazette, if the powder polymer is dissolved in water to form a jelly, the fluidity is improved, so that it can be easily injected into the nostrils, etc. It can be injected smoothly along the injection tube without being scattered. However, since the polymer is already dissolved in water, the water supply performance originally possessed by the polymer has almost disappeared. Therefore, the jelly is used only as a plug to fill the gap of the nostril, and cannot sufficiently seal the nostril.

【0011】粉体では鼻孔等の体腔に充填しにくい、ゼ
リーでは吸水性能が不足し、体腔を封止できない。その
ために、実際の現場では、相変わらずガーゼや脱脂綿で
応急処置しているだけであり、ガーゼや脱脂綿に代わる
体液漏出防止技術の実現が強く望まれている。
[0011] Powders do not easily fill body cavities such as nostrils, while jelly has insufficient water absorption properties and cannot seal body cavities. Therefore, in actual practice, only emergency treatment is performed with gauze or cotton wool as ever, and realization of a body fluid leakage prevention technology that replaces gauze or cotton wool is strongly desired.

【0012】本発明の第1の目的は、今までの樹脂粉末
では遺体の体液漏出を防止できないので、新規な体液漏
出防止材を開発したことを特徴とする。特に、ゼリーで
ありながら高い吸水性を有する体液漏出防止材を開発し
たことを特徴とする。
A first object of the present invention is characterized in that a new body fluid leakage preventive material has been developed because the body fluid cannot be prevented from leaking with the conventional resin powder. In particular, the invention is characterized by the development of a body fluid leakage preventive material having high water absorbency while being jelly.

【0013】第2の目的は、ポリマーが粉体の状態でゼ
リーの中に分散しているゼリー状の体液漏出防止材を使
用して、体腔を封止することを特徴とする。
A second object is to seal a body cavity by using a jelly-like body fluid leakage preventing material in which a polymer is dispersed in jelly in a powder state.

【0014】[0014]

【課題を解決するための手段】上記目的を達成するため
に、請求項1記載の発明は、遺体の体腔に装填される体
液漏出防止材が、ゼリ−の中に高吸水性粉体が多数分散
してなるので、体液漏出防止材の流動性が高く、鼻孔、
耳穴等の狭い体腔であっても充填されやすく、注入器で
圧入しても飛散することがない。その上、ゼリーにポリ
マーが分散しているので、ポリマーが吸水性能を維持し
ており、このポリマーが体腔から漏出する体液を吸収
し、外部へ漏出することを防止する。
In order to achieve the above object, according to the first aspect of the present invention, there is provided a body fluid leakage preventive material to be loaded into a body cavity of a corpse, wherein a large number of superabsorbent powders are contained in jelly. Because it is dispersed, the fluid of the body fluid leakage prevention material is high,
Even a narrow body cavity such as an ear hole is easily filled, and does not scatter even when pressed with an injector. In addition, since the polymer is dispersed in the jelly, the polymer maintains the water absorbing performance, and the polymer absorbs the body fluid leaking from the body cavity and prevents the polymer from leaking to the outside.

【0015】請求項2の発明は、請求項1記載のゼリー
状体液漏出防止材において、高吸水性粉体が微粉体から
なり、ゼリーの中に5,000個以上/ml分散してい
る構成であり、体液漏出防止材の流動性を確保しつつ、
吸水性を確保できるので、体腔を確実に封止できる。
According to a second aspect of the present invention, in the material for preventing leakage of jelly-like body fluid according to the first aspect, the superabsorbent powder is composed of fine powder, and 5,000 particles / ml or more are dispersed in the jelly. While ensuring the fluidity of the body fluid leakage prevention material,
Since water absorption can be ensured, the body cavity can be reliably sealed.

【0016】請求項3の発明は、請求項1記載のゼリー
状体液漏出防止材において、高吸水性粉体が微粉体から
なり、ゼリーの中に15,000個/ml〜30,00
0個/ml分散している構成であり、体液漏出防止材の
流動性を確保しつつ、吸水性を確保できるので、体腔を
更に確実に封止できる。
According to a third aspect of the present invention, there is provided the material for preventing leakage of jelly-like body fluid according to the first aspect, wherein the superabsorbent powder is a fine powder, and 15,000 particles / ml to 30,000 are contained in the jelly.
Since the composition is dispersed at 0 particles / ml and the fluid absorption of the body fluid leakage preventing material can be ensured while ensuring water absorption, the body cavity can be more securely sealed.

【0017】請求項4の発明は、請求項1記載のゼリー
状体液漏出防止材において、高吸水性粉体が60〜20
0メッシュの粉体からなり、ゼリーの中に18,000
個/ml〜25,000個/ml分散している構成であ
り、体液漏出防止材の流動性を確保しつつ、吸水性を確
保できるので、体腔封止機能が非常に高い。
According to a fourth aspect of the present invention, there is provided the material for preventing leakage of jelly-like body fluid according to the first aspect, wherein the superabsorbent powder contains 60 to 20 particles.
Made of 0 mesh powder, 18,000 in jelly
This is a configuration in which the number of particles / ml to 25,000 particles / ml are dispersed, and the water absorption can be ensured while ensuring the fluidity of the body fluid leakage prevention material, so that the body cavity sealing function is extremely high.

【0018】請求項5の発明は、請求項1ないし4のい
ずれか記載のゼリー状体液漏出防止材において、ゼリー
がエチレングリコール、プロピレングリコール、ジエチ
レングリコール、メタノール、エタノール、グリセリン
の少なくとも1種からなる構成であり、ゼリー状の中に
粉体を分散して保持できる。
According to a fifth aspect of the present invention, in the material for preventing jelly-like body fluid leakage according to any one of the first to fourth aspects, the jelly comprises at least one of ethylene glycol, propylene glycol, diethylene glycol, methanol, ethanol and glycerin. The powder can be dispersed and held in the jelly form.

【0019】請求項6の発明は、請求項1ないし5のい
ずれか記載のゼリー状体液漏出防止材において、ゼリー
はグリコール系を主成分とし、アクリル酸重合体、中和
剤が含まれる構成であり、粉体の吸水性を維持した状態
でゼリー状の中に分散して保持できる。
According to a sixth aspect of the present invention, there is provided the material for preventing leakage of jelly-like body fluid according to any one of the first to fifth aspects, wherein the jelly is mainly composed of a glycol system, and contains an acrylic acid polymer and a neutralizing agent. Yes, it can be dispersed and maintained in a jelly state while maintaining the water absorption of the powder.

【0020】請求項7の発明は、請求項1ないし6のい
ずれか記載のゼリー状体液漏出防止材において、アルコ
ール系主成分100重量部に対し、アクリル酸重合体が
0.01〜1.0重量部、中和剤が0.03〜0.7重
量部含まれる構成であり、粉体の吸水性を維持した状態
でゼリー状の中に分散して保持できる機能に優れてい
る。
[0020] The invention of claim 7 provides the jelly-like body fluid leakage preventive material according to any one of claims 1 to 6, wherein the acrylic acid polymer is contained in an amount of 0.01 to 1.0 with respect to 100 parts by weight of the alcohol-based main component. It is configured to contain 0.03 to 0.7 parts by weight of a neutralizing agent, and is excellent in a function of being able to be dispersed and held in a jelly state while maintaining the water absorption of the powder.

【0021】請求項8の発明は、請求項1ないし7のい
ずれか記載のゼリー状体液漏出防止材において、ゼリー
状体液漏出防止材の粘度が8,000〜40,000C
Pである構成であり、ゼリーの流動性が良いので、耳
孔、鼻孔、肛門、女性の膣・尿道などの狭い体腔通路も
スムーズに投入でき、適確に封止できる。
The invention of claim 8 is the jelly-like body fluid leakage preventive material according to any one of claims 1 to 7, wherein the viscosity of the jelly-like body fluid leakage prevention material is 8,000 to 40,000C.
Since the composition is P and the jelly has good fluidity, narrow body cavity passages such as the ear canal, the nostrils, the anus, and the female vagina / urethra can be inserted smoothly and sealed properly.

【0022】請求項9の発明は、請求項1ないし8のい
ずれか記載のゼリー状体液漏出防止材において、ゼリー
状体液漏出防止材のPHが7〜9である構成であり、粉
体の吸水性を維持した状態でゼリー状の中に分散して保
持でき、体液漏出防止機能に優れている。
According to a ninth aspect of the present invention, in the jelly-like body fluid leakage preventing material according to any one of the first to eighth aspects, the pH of the jelly-like body fluid leakage preventing material is 7 to 9; It can be dispersed and maintained in a jelly state while maintaining its properties, and is excellent in body fluid leakage prevention function.

【0023】請求項10の発明は、請求項1ないし9の
いずれか記載のゼリー状体液漏出防止材において、該体
液漏出防止材に薬液が含まれる構成であり、異臭を吸収
したり、作業中に作業者が病原菌に感染することを防止
できる。
According to a tenth aspect of the present invention, there is provided the jelly-like body fluid leakage preventing material according to any one of the first to ninth aspects, wherein the body fluid leakage preventing material contains a chemical solution to absorb an unpleasant odor, In addition, it is possible to prevent workers from being infected with pathogenic bacteria.

【0024】請求項11の発明は、請求項1ないし10
のいずれか記載のゼリー状体液漏出防止材を注入シリン
ダに入れ、注入シリンダの先端に取り付けた注入管の先
端を体腔に投入し、注入シリンダ内のゼリー状体液漏出
防止材を、注入管を介して体腔の所定位置に投入し、ゼ
リー状体液漏出防止材が体液を吸収することで体液漏出
を防止する方法であり、滑らかに体腔に体液漏出防止材
を装填でき、かつ漏出する体液を十分に吸収できる。ま
た、体腔に注入する際に、ゼリーが飛散しないし、漏出
もしないので周辺を汚す恐れもない。
[0024] The invention of claim 11 is the invention according to claims 1 to 10
Put the jelly-like body fluid leakage prevention material according to any of the above into an injection cylinder, put the tip of an injection tube attached to the tip of the injection cylinder into the body cavity, and place the jelly-like body fluid leakage prevention material in the injection cylinder through the injection tube. Into the body cavity at a predetermined position, and the jelly-like body fluid leakage prevention material absorbs the body fluid to prevent body fluid leakage.The body cavity can be smoothly loaded with the body fluid leakage prevention material, and the leaking body fluid is sufficiently removed. Can be absorbed. Also, when injected into the body cavity, the jelly does not scatter or leak, so there is no danger of staining the surroundings.

【0025】本発明で使用する高吸水性ポリマーは、ゼ
リー中に粉体で分散混在しているが、体液を吸収して確
実に漏出を防止するためには、ゼリーの中に5,000
個以上/ml分散していることが好ましい。特に、高吸
水性ポリマーが微粉体からなり、ゼリーの中に15,0
00個/ml〜30,000個/ml分散していること
が更に好ましい。その上更に、高吸水性粉体が60〜2
00メッシュの粉体からなり、ゼリーの中に18,00
0個/ml〜25,000個/ml分散していると体液
漏出効果が非常に高い。
The superabsorbent polymer used in the present invention is dispersed and mixed as a powder in the jelly. However, in order to absorb body fluid and reliably prevent leakage, the 5,000 jelly is contained in the jelly.
It is preferable that the particles are dispersed in a number of particles / ml or more. In particular, the superabsorbent polymer is composed of fine powder, and 15.0
More preferably, the dispersion is from 00 / 30,000 / ml. Furthermore, the superabsorbent powder is 60 to 2
It is made of 00 mesh powder and contains 1800
When the number of particles is 0 to 25,000 / ml, the effect of leaking body fluid is very high.

【0026】本発明で使用するゼリーの粘液基材として
は、エチレングリコール、プロピレングリコール、ジエ
チレングリコール、メタノール、エタノール、グリセリ
ンの中から選ばれた少なくとも一種を用いることが好ま
しい。特に、グリコール系はアクリル酸系ポリマーを粉
体の状態で分散して保持している状態が安定しており、
好ましい。エチレングリコールが取り扱いが容易であっ
て、半年以上放置しても、内部に分散している微粉体が
溶けることなく、長期間安定して粉体の状態を維持する
ことができた。
It is preferable to use at least one selected from the group consisting of ethylene glycol, propylene glycol, diethylene glycol, methanol, ethanol, and glycerin as the mucous base material of the jelly used in the present invention. In particular, the glycol type is stable in a state where the acrylic acid type polymer is dispersed and held in a powder state,
preferable. Ethylene glycol was easy to handle, and even if left for more than half a year, the fine powder dispersed therein did not melt, and the powder state could be stably maintained for a long period of time.

【0027】ゼリーとしては、粘液基材としてのアルコ
ール系主成分100重量部に対し、アクリル酸重合体が
0.01〜1.0重量部、中和剤が0.03〜0.7重
量部含まれることが好ましい。特に、アクリル酸は、安
定したゼリーを生成するために必要であり、0.01重
量部未満では粘度が不足する。一方1.0重量部より多
くなると、粘度が飽和点に達し、それ以上は多くしても
粘度は上がらない。
As the jelly, 0.01 to 1.0 parts by weight of an acrylic acid polymer and 0.03 to 0.7 parts by weight of a neutralizing agent are used based on 100 parts by weight of an alcohol-based main component as a mucous base material. Preferably, it is included. In particular, acrylic acid is necessary for producing a stable jelly, and if it is less than 0.01 part by weight, the viscosity becomes insufficient. On the other hand, if the amount is more than 1.0 part by weight, the viscosity reaches the saturation point, and if it is more than that, the viscosity does not increase.

【0028】中和剤はゼリーのPHを適正な値に維持す
るために必要であり、0.03重量部未満では、PHが
下がり、その結果ゼリーの粘性が不足し、粘度の有効な
範囲を外れる。一方、0.7重量部より多くなると、ゼ
リーの粘性が安定しなくなり、調整が困難となる。
The neutralizing agent is necessary to maintain the pH of the jelly at an appropriate value. When the neutralization agent is less than 0.03 parts by weight, the pH decreases, and as a result, the viscosity of the jelly becomes insufficient, and the effective range of the viscosity is reduced. Come off. On the other hand, if it exceeds 0.7 parts by weight, the viscosity of the jelly becomes unstable, and the adjustment becomes difficult.

【0029】ゼリー状体液漏出防止材の粘度は8,00
0〜40,000CPであることが好ましい。この値よ
りも粘度が低いとさらさらとなり、体腔には入りやすい
が、所定位置に留まることがなく、封止効果が期待でき
ない。一方、40,000CPよりも多すぎると粘性が
高すぎて、体腔に注入することが難しくなる。
The viscosity of the jelly-like body fluid leakage preventing material is 8,000.
It is preferably from 0 to 40,000 CP. If the viscosity is lower than this value, it becomes smooth and easily enters the body cavity, but does not stay at a predetermined position, and the sealing effect cannot be expected. On the other hand, if it is more than 40,000 CP, the viscosity is too high and it is difficult to inject it into the body cavity.

【0030】ゼリー状体液漏出防止材のPHは7〜9に
調整することが好ましい。PHが7よりも少なくなる
と、ゼリーの粘性が不足し、粘度の有効な範囲を外れ
る。一方PHが9より高くなると、粘度が変動して不安
定となり、体腔に注入することが難しくなるので、好ま
しくない。PHはゼリーの粘度を適正な値にするバロメ
ーターとして使われる。
The pH of the jelly-like body fluid leakage preventive is preferably adjusted to 7 to 9. If the pH is less than 7, the viscosity of the jelly becomes insufficient, and the viscosity falls outside the effective range of the viscosity. On the other hand, if the pH is higher than 9, the viscosity fluctuates and becomes unstable, making it difficult to inject into the body cavity. PH is used as a barometer to adjust the viscosity of jelly to an appropriate value.

【0031】該体液漏出防止材には、二酸化安定塩素、
消臭剤、殺菌剤、防腐剤等の薬液を添加しても良い。
The body fluid leakage preventing material includes stable chlorine dioxide,
A chemical such as a deodorant, a bactericide, or a preservative may be added.

【0032】本発明に係わるゼリー状体液漏出防止材の
製造方法を説明する。攪拌機に粘液基材であるエチレン
グリコールを入れる。このエチレングリコールを攪拌し
ながら、アクリル酸重合体を少量づつ加えていく。2〜
8時間攪拌して、分散液を生成する。この分散液を攪拌
しながら、中和剤を少量づつ滴下していく。これによ
り、ゼリーが生成される。このゼリーにゲル粉末である
高吸水性ポリマーを加え、十分に攪拌する。これによ
り、ポリマーが分散したゼリーが生成される。
The method for producing the jelly-like body fluid leakage preventing material according to the present invention will be described. The ethylene glycol which is a mucus base material is put into a stirrer. While stirring the ethylene glycol, the acrylic acid polymer is added little by little. Two
Stir for 8 hours to produce a dispersion. While stirring the dispersion, the neutralizing agent is added dropwise little by little. Thereby, jelly is produced. A superabsorbent polymer, which is a gel powder, is added to the jelly and stirred sufficiently. This produces a jelly in which the polymer is dispersed.

【0033】[0033]

【発明の実施の形態】以下、本発明の実施形態を図面に
基づいて説明する。図1により、本発明に係わるゼリー
状体液漏出防止材を鼻孔奥の咽喉部に充填する場合の充
填方法を説明する。ゼリー状の体液漏出防止材8を注入
器1に入れる。注入器1は、その先端に保護キャップ3
を被せた注入口2を備え、フイルムパック(図示せず)
で包んでシールした状態にしておく。それと、咽喉部B
等の体腔に挿入される挿入管4を用意しておく。挿入管
4は、一端に注入器1の注入口2に接続される接続部5
を有し、他端に鼻孔Aに挿入される開口部6を有する。
挿入管4は挿入しやすいように先端が先細に形成され、
開口部6を挿入方向及び側方に開口している。
Embodiments of the present invention will be described below with reference to the drawings. With reference to FIG. 1, a method of filling the jelly-like body fluid leakage preventive material according to the present invention into the throat deep inside the nostrils will be described. The jelly-like body fluid leakage preventing material 8 is put into the injector 1. The syringe 1 has a protective cap 3 at its tip.
Film pack (not shown)
Wrap and seal. And throat B
An insertion tube 4 to be inserted into a body cavity such as is prepared. The insertion tube 4 is provided at one end with a connection portion 5 connected to the injection port 2 of the injector 1.
And an opening 6 to be inserted into the nostril A at the other end.
The tip of the insertion tube 4 is tapered to facilitate insertion,
The opening 6 is opened in the insertion direction and the side.

【0034】図1は、このようにして用意された体液漏
出防止装置を遺体に使用する状態を示す。Aは鼻孔、B
は咽喉部、Cは舌、Dは気管、Eは食道、Fは頚椎であ
る。使用時には、フイルムパックから注入器1を取り出
し、注入器1の注入口2の保護キャップ3を取り外し、
代わりに挿入管4の接続部5を被せて接続する。挿入管
4の開口部6を鼻孔Aから咽喉部Bに向けて挿入し、挿
入管4のストッパ部7が鼻先Bに当たった時点で挿入を
中止する。そして、注入器1のピストン1aを押圧し、
注入器1内のゼリー状の体液漏出防止材8を挿入管4を
経由して咽喉部Bに注入する。挿入管4の開口部6は挿
入方向先端だけでなく、側面にも開口しているので、一
部開口部が詰まっても咽喉部Bに導入される。注入器1
内の体液漏出防止材8を押出した後は、注入器1と挿入
管4を鼻孔Aから取り除く。
FIG. 1 shows a state in which the body fluid leakage prevention device thus prepared is used for a corpse. A is nostril, B
Is the throat, C is the tongue, D is the trachea, E is the esophagus, and F is the cervical spine. At the time of use, take out the injector 1 from the film pack, remove the protective cap 3 of the inlet 2 of the injector 1,
Instead, the connection part 5 of the insertion tube 4 is put on and connected. The opening 6 of the insertion tube 4 is inserted from the nostril A toward the throat B, and the insertion is stopped when the stopper 7 of the insertion tube 4 hits the nose B. Then, the piston 1a of the injector 1 is pressed,
The jelly-like body fluid leakage prevention material 8 in the injector 1 is injected into the throat B via the insertion tube 4. Since the opening 6 of the insertion tube 4 is open not only at the distal end in the insertion direction but also at the side, even if the opening is partially blocked, it is introduced into the throat B. Injector 1
After the body fluid leakage preventive member 8 is extruded, the injector 1 and the insertion tube 4 are removed from the nostrils A.

【0035】この実施例では、複数の開口部6から咽喉
部Bに集中的に体液漏出防止材8が流し込まれる。特
に、ゼリーの状態で流し込まれるので流動性が非常によ
く、軽い力で滑らかに充填できる。粉末のように拡散し
て鼻孔Aから飛び出たりすることがなく、この体液漏出
防止材8が咽喉部Bに留まり、咽喉部Bが封止される。
本発明のゼリーは、粉体と違って非常に流動性があるの
で、鼻奥の咽喉部でも細い挿入管4を介して必要部位に
投入でき、耳孔の奥、肛門、女性の膣などにも楽に充填
でき、体液の漏出を封止できる。また、充填時の音が比
較的静かであり、作業者は周囲の人たちを気にせずに作
業できる。
In this embodiment, the body fluid leakage preventive material 8 is intensively poured into the throat B from the plurality of openings 6. In particular, since it is poured in a jelly state, it has very good fluidity and can be smoothly filled with a light force. The bodily fluid leakage preventing material 8 stays in the throat part B without being diffused like a powder and jumping out of the nostrils A, and the throat part B is sealed.
Since the jelly of the present invention has a very fluidity unlike powder, it can be injected into a required site through a thin insertion tube 4 even in the throat in the back of the nose, and can be injected into the back of the ear canal, the anus, and the female vagina. It can be filled easily and can prevent leakage of bodily fluids. In addition, the sound at the time of filling is relatively quiet, and the worker can work without worrying about the surrounding people.

【0036】挿入抵抗を軽減するために、挿入管4に潤
滑剤を塗布しても良い。挿入管4と注入器1とを接続し
て鼻孔Aに挿入したが、挿入管4を先に鼻孔Aに挿入
し、それから挿入管4に注入器1を接続しても良い。注
入器と挿入管とをいっしょにフイルムパックで包んでも
良い。注入器と挿入管は初めから接続されたものでも、
または一体に作られたものでも良い。ストッパの代わり
にマークを付与したものでも、挿入位置のばらつきを防
止できる。
A lubricant may be applied to the insertion tube 4 to reduce the insertion resistance. Although the insertion tube 4 and the injector 1 are connected and inserted into the nostril A, the insertion tube 4 may be inserted into the nostril A first, and then the injector 1 may be connected to the insertion tube 4. The injector and the insertion tube may be wrapped together in a film pack. The injector and the insertion tube are connected from the beginning,
Or it may be made integrally. Even if a mark is provided instead of the stopper, variation in the insertion position can be prevented.

【0037】図2は第2実施例を示す。第1実施例と同
様な体液漏出防止材8が充填された注入器を肛門に挿入
される肛門封止部材10に使用する実施例である。肛門
封止部材10は、射出成形樹脂材からなり、芯部材1
1、案内部材13及びストッパ部材16を備えている。
芯部材11が中空の円筒形状であって、内部に前後方向
に貫通する中空部12が形成されている。案内部材13
は内部に中空部が形成され、この中空部を囲む筒部14
が長手方向後方に延びて設けられている。筒部14の前
方は挿入時の案内部15として曲線状に先細に形成され
ており、筒部14の外周に間隙17を開けて延長部18
が前方から長手方向後方かつ外方に延びるように設けら
れている。芯部材11の前部が間隙17に挿入されるよ
うに、芯部材11の中空部12に案内部材13の筒部1
4が挿入嵌合される。ストッパ部材16の前部には、芯
部材11の中空部12に嵌合される筒部19が設けら
れ、ストッパ部材16の後部には、幅広のフランジ形状
の当て部材20が一体に形成されている。芯部材11の
中空部12と案内部材13の筒部14、芯部材11の中
空部12とストッパ部材16の筒部19との間には、互
いに嵌り合う凸部21と凹部22が形成されている。
FIG. 2 shows a second embodiment. This is an embodiment in which an injector filled with the same body fluid leakage preventive material 8 as in the first embodiment is used for the anal sealing member 10 inserted into the anus. The anal sealing member 10 is made of an injection-molded resin material,
1, a guide member 13 and a stopper member 16 are provided.
The core member 11 has a hollow cylindrical shape, and a hollow portion 12 penetrating in the front-rear direction is formed inside. Guide member 13
Has a hollow portion formed therein, and a cylindrical portion 14 surrounding the hollow portion.
Is provided to extend rearward in the longitudinal direction. The front portion of the cylindrical portion 14 is formed into a curved tapered shape as a guide portion 15 at the time of insertion.
Are provided to extend longitudinally rearward and outward from the front. The cylindrical portion 1 of the guide member 13 is inserted into the hollow portion 12 of the core member 11 so that the front portion of the core member 11 is inserted into the gap 17.
4 is inserted and fitted. At the front of the stopper member 16, there is provided a cylindrical portion 19 fitted into the hollow portion 12 of the core member 11, and at the rear of the stopper member 16, a wide flange-shaped contact member 20 is integrally formed. I have. Between the hollow portion 12 of the core member 11 and the cylindrical portion 14 of the guide member 13, and between the hollow portion 12 of the core member 11 and the cylindrical portion 19 of the stopper member 16, a convex portion 21 and a concave portion 22 that fit each other are formed. I have.

【0038】芯部材11を包むように巻かれるゴム部材
23が上記凸部21と上記凹部22で挟持されるように
なっている。筒部14の外径が先端方向に向けて幅広に
なるようにテーパーになっており、芯部材11の前部の
内径も同様にテーパ−になっている。また、筒部19の
外径は当て部材20方向に向けて幅広になるようにテー
パーになっており、芯部材11の後部の内径も同様にテ
ーパ−になっている。このテーパーによりゴム部材23
が巻き込まれた時にゴム部材23のたるみが少なくなる
ようになっている。
A rubber member 23 wound around the core member 11 is sandwiched between the convex portion 21 and the concave portion 22. The outer diameter of the cylindrical portion 14 is tapered so as to become wider toward the distal end, and the inner diameter of the front portion of the core member 11 is also tapered. The outer diameter of the cylindrical portion 19 is tapered so as to become wider toward the contact member 20, and the inner diameter of the rear portion of the core member 11 is also tapered. The rubber member 23 is formed by this taper.
Is reduced so that the slack of the rubber member 23 is reduced.

【0039】芯部材11の外周に、小径の段部24が設
けられ、そこに4つのスリット孔25が形成されてい
る。この段部24にゴム製のバンド26が巻かれてい
る。バンド26はスリット孔25を閉めるように、段部
24の外径より少し小径のものが伸ばされて巻かれてい
る。
A small-diameter step portion 24 is provided on the outer periphery of the core member 11, and four slit holes 25 are formed therein. A rubber band 26 is wound around the step 24. The band 26 has a diameter slightly smaller than the outer diameter of the step portion 24 and is wound so as to close the slit hole 25.

【0040】ストッパ部材16の筒部19の内部には導
入通路27が貫通して形成されている。当て部材20は
筒部19の途中から略直行する方向に滑らかな曲線で延
びて、先端が楕円形状になるように設けられている。当
て部材20の外周、即ち肛門周辺の皮膚と接触する面に
接触面材28が貼り付けてある。接触面材28として
は、スポンジ、フェルト、吸収剤層、ゲル剤層、接着剤
層、接着テープ等が用いられる。当て部材20の内周に
は、筒部19の先端を覆うようにカバー部材29が貼り
付けられている。このカバー部材29の中央部、即ちス
トッパ部材16の筒部19の先端に対面する部分には、
十字形状の切込み30またはスリットが開けられてお
り、注入器(図示せず)を筒部19の先端にセットする
時には、妨げにならず、通常は筒部19の先端を隠すよ
うになっており、見栄えを良くしている。
An introduction passage 27 is formed through the inside of the cylindrical portion 19 of the stopper member 16. The contact member 20 extends in a direction substantially perpendicular to the middle of the cylindrical portion 19 with a smooth curve, and is provided such that its tip is elliptical. A contact surface member 28 is attached to the outer periphery of the contact member 20, that is, the surface that comes into contact with the skin around the anus. As the contact surface member 28, a sponge, a felt, an absorbent layer, a gel agent layer, an adhesive layer, an adhesive tape, or the like is used. A cover member 29 is attached to the inner periphery of the contact member 20 so as to cover the tip of the tubular portion 19. The central portion of the cover member 29, that is, the portion of the stopper member 16 facing the tip of the cylindrical portion 19,
A cross-shaped cut 30 or slit is provided so that when an injector (not shown) is set at the tip of the tube portion 19, it does not hinder and usually hides the tip of the tube portion 19. , Looks better.

【0041】可撓性部材として膨張するゴム部材23
が、芯部材11の外周に調整室31を設けて芯部材11
に被せられている。ゴム部材23は両方が開口した筒状
部材であって、一方の開口部分が芯部材11の中空部1
2とストッパ部材16の筒部19との間で挟持され、他
方の開口部分が芯部材11の中空部12と案内部材13
の筒部14との間で挟持される。
Rubber member 23 which expands as a flexible member
However, an adjustment chamber 31 is provided on the outer periphery of the core
Is covered. The rubber member 23 is a tubular member that is open at both ends, and one of the openings is the hollow portion 1 of the core member 11.
2 and the cylindrical portion 19 of the stopper member 16, and the other opening portion has the hollow portion 12 of the core member 11 and the guide member 13.
Between the cylindrical portion 14 and the cylindrical portion 14.

【0042】したがって、芯部材11の中空部12とス
トッパ部材16の導入通路27との連通がゴム部材23
で塞がれることが無い。なお、この実施例では、筒状の
ゴム部材で説明したが、袋状のゴム部材いわゆるゴム風
船であってもよい。
Therefore, the communication between the hollow portion 12 of the core member 11 and the introduction passage 27 of the stopper member 16 is established by the rubber member 23.
There is no blockage. In this embodiment, a cylindrical rubber member has been described, but a bag-shaped rubber member, a so-called rubber balloon, may be used.

【0043】この実施例では、互いに嵌り合う凸部21
と凹部22は周方向には数個設けられているが、適当な
数設ければよいものである。凸部21と凹部22は1列
であるが、複数列にしても良く、凸部と凹部は反対に設
けても良い。この実施例では4箇所にスリット孔25を
設けているが、これに限られるものではなく、1個でも
よく、又5個以上でも良い。また、スリット孔に限ら
ず、機能を満足する連通孔であれば他の形状でも良い。
これらの芯部材11、案内部材13及びストッパ部材1
6は射出成形樹脂材からなるので、安定した形状を量産
でき、さらに、遺体といっしょに焼却する時でも有害成
分の発生問題はない。
In this embodiment, the projections 21 fitted to each other
Although several recesses 22 are provided in the circumferential direction, an appropriate number may be provided. Although the convex portion 21 and the concave portion 22 are arranged in one row, they may be arranged in a plurality of rows, and the convex portion and the concave portion may be provided in reverse. In this embodiment, the slit holes 25 are provided at four positions. However, the number of slit holes 25 is not limited to four, and may be one or five or more. Further, the shape is not limited to the slit hole, and may be another shape as long as the communication hole satisfies the function.
These core member 11, guide member 13, and stopper member 1
6 is made of an injection-molded resin material, so that a stable shape can be mass-produced, and there is no problem of generating harmful components even when incinerated together with a corpse.

【0044】作業時は、肛門封止部材10を肛門に押し
込み、当て部材20の接触面材28が肛門周辺皮膚に当
たるまで挿入する。その後、切込み30から注入器(図
示せず)を筒部19の先端にセットし、注入器のピスト
ンを押し込む。これにより、注入器内部の体液漏出防止
材が導入通路27、芯部材11の中空部12、スリット
孔25を通って、ゴム製バンド26を押し広げて調整室
31に導入される。それによって、ゴム部材23が膨張
し、体腔内壁に密着するようになる。
In operation, the anal sealing member 10 is pushed into the anus and inserted until the contact surface member 28 of the contact member 20 hits the skin around the anus. Thereafter, an injector (not shown) is set at the tip of the cylindrical portion 19 from the cut 30 and the piston of the injector is pushed in. Thereby, the body fluid leakage preventing material inside the injector passes through the introduction passage 27, the hollow portion 12 of the core member 11, and the slit hole 25, pushes the rubber band 26, and is introduced into the adjustment chamber 31. As a result, the rubber member 23 expands and comes into close contact with the inner wall of the body cavity.

【0045】図1では鼻孔から導入し、咽喉部を封止す
る実施例で本発明を説明したが、遺体の口腔、鼻孔その
もの、耳孔、尿道、肛門、女性の膣に適用しても良い。
また、事故や手術後の遺体の傷口や開口部分にも適用し
ても良い。
In FIG. 1, the present invention has been described with an embodiment in which the throat is introduced through the nostrils, but the present invention may be applied to the oral cavity of the body, the nares itself, the ear canal, the urethra, the anus, and the female vagina.
Further, the present invention may be applied to a wound or an opening of a corpse after an accident or an operation.

【0046】図示しないが、ゼリー状の体液漏出防止材
8が水溶性フイルムに包まれて用意されているか、ある
いはゼリー状の体液漏出防止材8を包むものが先端から
滑らかな形状で膨らんで、その後後方に向けて滑らかに
小径になったカプセル形状に形成され、その表面に潤滑
剤が塗布されて用意されていることも可能である。特に
肛門、女性の膣・尿道に対しては、座薬を挿入する感覚
で装填でき、作業も比較的楽である。
Although not shown, the jelly-like body fluid leakage preventive member 8 is prepared by being wrapped in a water-soluble film, or the jelly-like body fluid leakage preventive member 8 is swelled in a smooth shape from the tip. Thereafter, it may be formed into a capsule shape having a small diameter smoothly toward the rear, and a lubricant may be applied to the surface of the capsule. In particular, the anus and the female vagina and urethra can be loaded with the sensation of inserting a suppository, and the work is relatively easy.

【0047】[0047]

【発明の効果】本発明では、内部に粉体が分散したゼリ
ー状の体液漏出防止材であるので、この体液漏出防止材
は流動性があり、滑らかに体腔内に注入でき、必要部位
に集中的に充填し留めることができる。それと同時に体
液漏出防止材内部に粉体を分散保持しているので、この
粉体により、体内から出てくる体液を吸収でき、体液が
体外に漏出することを防止できる。
According to the present invention, since the jelly-like body fluid leakage preventing material in which powder is dispersed therein, the body fluid leakage preventing material has fluidity, can be smoothly injected into a body cavity, and can be concentrated at a necessary site. It can be filled and stopped. At the same time, since the powder is dispersed and held inside the body fluid leakage prevention material, the powder can absorb the body fluid coming out of the body and prevent the body fluid from leaking out of the body.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明にかかわる体液漏出防止装置の使用状態
を示す図である。
FIG. 1 is a diagram showing a use state of a body fluid leakage prevention device according to the present invention.

【図2】(a)及び(b)は本発明の別の実施例を示す
縦断側面図及び背面図である。
2 (a) and 2 (b) are a longitudinal side view and a rear view showing another embodiment of the present invention.

【符号の説明】[Explanation of symbols]

1 注入器 2 注入口 3 保護キャップ 4 挿入管 5 接続部 6 開口部 7 ストッパ部 8 両親媒性ゲル A 鼻孔 B 咽喉部 C 舌 D 気管 E 食道 F 頚椎 10 肛門封止部材 11 芯部材 12 中空部 13 案内部材 14 筒部 15 案内部 16 ストッパ部材 17 間隙 18 延長部 19 筒部 20 当て部材 21 凸部 22 凹部 23 ゴム部材 24 段部 25 スリット孔 26 バンド 27 導入通路 28 接触面材 29 カバー部材 30 切込み 31 調整室 DESCRIPTION OF SYMBOLS 1 Injector 2 Injection port 3 Protective cap 4 Insertion tube 5 Connection part 6 Opening part 7 Stopper part 8 Amphiphilic gel A Nostril B Throat C Tongue D Trachea E Esophagus F Cervical vertebra 10 Anal sealing member 11 Core member 12 Hollow part DESCRIPTION OF SYMBOLS 13 Guide member 14 Tube part 15 Guide part 16 Stopper member 17 Gap 18 Extension part 19 Tube part 20 Abutment member 21 Convex part 22 Depression 23 Rubber member 24 Step 25 Slit hole 26 Band 27 Introductory passage 28 Contact surface material 29 Cover member 30 Cut 31 Adjustment room

Claims (11)

【特許請求の範囲】[Claims] 【請求項1】 遺体の体腔に装填される体液漏出防止材
が、ゼリ−の中に高吸水性粉体が多数分散してなること
を特徴とするゼリー状体液漏出防止材。
1. A jelly-like body fluid leakage prevention material, wherein the body fluid leakage prevention material loaded in a body cavity of a corpse is formed by dispersing a large number of superabsorbent powders in jelly.
【請求項2】 高吸水性粉体が微粉体からなり、ゼリー
の中に5,000個以上/ml分散していることを特徴
とする請求項1記載のゼリー状体液漏出防止材。
2. The material for preventing leakage of jelly-like body fluid according to claim 1, wherein the superabsorbent powder is composed of fine powder and is dispersed in the jelly in an amount of 5,000 particles / ml or more.
【請求項3】 高吸水性粉体が微粉体からなり、ゼリー
の中に15,000個/ml〜30,000個/ml分
散していることを特徴とする請求項1記載のゼリー状体
液漏出防止材。
3. The jelly-like body liquid according to claim 1, wherein the superabsorbent powder is a fine powder and is dispersed in the jelly at 15,000 particles / ml to 30,000 particles / ml. Leak prevention material.
【請求項4】 高吸水性粉体が60〜200メッシュの
粉体からなり、ゼリーの中に18,000個/ml〜2
5,000個/ml分散していることを特徴とする請求
項1記載のゼリー状体液漏出防止材。
4. The superabsorbent powder is composed of 60-200 mesh powder, and contains 18,000 particles / ml-2 jelly in the jelly.
The jelly-like body fluid leakage preventing material according to claim 1, wherein the material is dispersed at 5,000 particles / ml.
【請求項5】 ゼリーがエチレングリコール、プロピレ
ングリコール、ジエチレングリコール、メタノール、エ
タノール、グリセリンの少なくとも1種からなることを
特徴とする請求項1ないし4のいずれか記載のゼリー状
体液漏出防止材。
5. The material for preventing leakage of jelly-like body fluid according to claim 1, wherein the jelly comprises at least one of ethylene glycol, propylene glycol, diethylene glycol, methanol, ethanol and glycerin.
【請求項6】 ゼリーはアルコール系を主成分とし、ア
クリル酸重合体、中和剤が含まれることを特徴とする請
求項1ないし5のいずれか記載のゼリー状体液漏出防止
材。
6. The material for preventing leakage of jelly-like body fluid according to claim 1, wherein the jelly is mainly composed of an alcohol, and contains an acrylic acid polymer and a neutralizing agent.
【請求項7】 アルコール系主成分100重量部に対
し、アクリル酸重合体が0.01〜1.0重量部、中和
剤が0.03〜0.7重量部含まれることを特徴とする
請求項1ないし6のいずれか記載のゼリー状体液漏出防
止材。
7. An alcohol-based polymer is contained in an amount of 0.01 to 1.0 part by weight and a neutralizing agent in an amount of 0.03 to 0.7 part by weight based on 100 parts by weight of the alcohol-based main component. The jelly-like body fluid leakage preventing material according to any one of claims 1 to 6.
【請求項8】 ゼリー状体液漏出防止材の粘度が8,0
00〜40,000CPであることを特徴とする請求項
1ないし7のいずれか記載のゼリー状体液漏出防止材。
8. The jelly-like body fluid leakage preventing material has a viscosity of 8.0 or less.
The jelly-like body fluid leakage preventive material according to any one of claims 1 to 7, wherein the material has a CP of 00 to 40,000 CP.
【請求項9】 ゼリー状体液漏出防止材のPHが7〜9
であることを特徴とする請求項1ないし8のいずれか記
載のゼリー状体液漏出防止材。
9. The jelly-like body fluid leakage preventive material has a pH of 7 to 9.
The jelly-like body fluid leakage preventive material according to any one of claims 1 to 8, wherein:
【請求項10】 該体液漏出防止材に薬液が含まれるこ
とを特徴とする請求項1ないし9のいずれか記載のゼリ
ー状体液漏出防止材。
10. The jelly-like body fluid leakage prevention material according to claim 1, wherein the body fluid leakage prevention material contains a chemical solution.
【請求項11】 請求項1ないし10のいずれか記載の
ゼリー状体液漏出防止材を注入シリンダに入れ、注入シ
リンダの先端に取り付けた注入管の先端を体腔に投入
し、注入シリンダ内のゼリー状体液漏出防止材を注入管
を介して、体腔の所定位置に投入し、ゼリー状体液漏出
防止材が体液を吸収することで体液漏出を防止すること
を特徴とする体液漏出防止方法。
11. The jelly-like body fluid leakage preventive material according to any one of claims 1 to 10 is put into an injection cylinder, and the tip of an injection tube attached to the tip of the injection cylinder is thrown into a body cavity, and the jelly-like substance in the injection cylinder is set. A method for preventing body fluid leakage, comprising introducing a body fluid leakage prevention material into a predetermined position of a body cavity via an infusion tube, and preventing the body fluid leakage by absorbing the body fluid with the jelly-like body fluid leakage prevention material.
JP2001078131A 2001-03-19 2001-03-19 Jelly-like body fluid leakage prevention material and body fluid leakage prevention method using the same Expired - Lifetime JP3586207B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001078131A JP3586207B2 (en) 2001-03-19 2001-03-19 Jelly-like body fluid leakage prevention material and body fluid leakage prevention method using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001078131A JP3586207B2 (en) 2001-03-19 2001-03-19 Jelly-like body fluid leakage prevention material and body fluid leakage prevention method using the same

Publications (2)

Publication Number Publication Date
JP2002275001A true JP2002275001A (en) 2002-09-25
JP3586207B2 JP3586207B2 (en) 2004-11-10

Family

ID=18934785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001078131A Expired - Lifetime JP3586207B2 (en) 2001-03-19 2001-03-19 Jelly-like body fluid leakage prevention material and body fluid leakage prevention method using the same

Country Status (1)

Country Link
JP (1) JP3586207B2 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093540A1 (en) * 2003-04-21 2004-11-04 Risa Nishihara Remains fluid leakage prevention device
WO2006043306A1 (en) * 2004-10-18 2006-04-27 Nishihara, Risa Body cavity sealing member, process for producing the same and apparatus for treating dead body
WO2006077617A1 (en) * 2005-01-18 2006-07-27 Nishihara, Risa Apparatus for caring dead body
JP2006256973A (en) * 2005-03-15 2006-09-28 Kankyo Keikaku Kk Aseptic agent and aseptic method
JP2007099669A (en) * 2005-10-04 2007-04-19 Nishihara Risa Material for preventing leakage of body fluid from dead body
WO2007077815A1 (en) 2006-01-04 2007-07-12 Azex Corporation Composition for dead body treatment and method of treating
WO2007092340A2 (en) * 2006-02-02 2007-08-16 H.B. Fuller Licensing & Financing, Inc. Mortuary articles including hot melt superabsorbent polymer composition, and methods of using and methods of making the same
JP2007222558A (en) * 2006-02-27 2007-09-06 Risa Nishihara System for preventing body liquid from leaking from dead body
JP2007223996A (en) * 2006-02-27 2007-09-06 Risa Nishihara Apparatus for sealing throat part of dead body
WO2007108536A1 (en) * 2006-03-23 2007-09-27 Axis International Co., Ltd. Body fluid leakage preventive for dead body and dead body treating equipment using the same
WO2007108538A1 (en) * 2006-03-23 2007-09-27 Axis International Co., Ltd. Corpse treatment device
WO2008126412A1 (en) 2007-04-09 2008-10-23 Risa Nishihara Container and supply pipe connecting structure, container, and supply pipe
JP2009179581A (en) * 2008-01-30 2009-08-13 Model Create:Kk Agent for preventing body fluid leakage for corpse and apparatus for preventing and treating body fluid leakage
EP1752042A4 (en) * 2004-05-21 2011-08-03 Nishihara Risa Apparatus for closing body cavity of dead body and method of treating dead body
KR101061369B1 (en) 2011-02-14 2011-09-01 남승현 Leakage of fluid from the body to manufacture blockers and prepared by the preparation method leaking of fluid from the body-blockers
WO2012129565A1 (en) * 2011-03-24 2012-09-27 Greenblendz, Inc. Improved tissue preservation fluid
WO2012137510A1 (en) * 2011-04-08 2012-10-11 Nishihara Risa Fluid leakage inhibitor
JP5368972B2 (en) * 2007-04-09 2013-12-18 梨沙 西原 Container and supply pipe
KR101384762B1 (en) * 2012-08-08 2014-04-14 남승현 Filter manufacturing method for preventing leakage of fluid from the body and a preparation method for preventing leakage of fluid from the body produced by the filter

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093540A1 (en) * 2003-04-21 2004-11-04 Risa Nishihara Remains fluid leakage prevention device
EP1752042A4 (en) * 2004-05-21 2011-08-03 Nishihara Risa Apparatus for closing body cavity of dead body and method of treating dead body
JP4602348B2 (en) * 2004-10-18 2010-12-22 西原 梨沙 Body cavity sealing member
WO2006043306A1 (en) * 2004-10-18 2006-04-27 Nishihara, Risa Body cavity sealing member, process for producing the same and apparatus for treating dead body
JPWO2006043306A1 (en) * 2004-10-18 2008-05-22 西原 梨沙 Body cavity sealing member, manufacturing method thereof, and corpse treatment apparatus
US7841054B2 (en) 2004-10-18 2010-11-30 Risa Nishihara Body cavity sealing member, method for manufacturing the same, and corpse treatment device
WO2006077617A1 (en) * 2005-01-18 2006-07-27 Nishihara, Risa Apparatus for caring dead body
US7644477B2 (en) 2005-01-18 2010-01-12 Risa Nishihara Corpse treatment device
AU2005325439B2 (en) * 2005-01-18 2010-05-13 Nishihara, Risa Corpse treatment device
JP2006256973A (en) * 2005-03-15 2006-09-28 Kankyo Keikaku Kk Aseptic agent and aseptic method
JP2007099669A (en) * 2005-10-04 2007-04-19 Nishihara Risa Material for preventing leakage of body fluid from dead body
WO2007077815A1 (en) 2006-01-04 2007-07-12 Azex Corporation Composition for dead body treatment and method of treating
KR100988673B1 (en) * 2006-01-04 2010-10-18 아젝스 코포레이션 Composition for dead body treatment and method of treating
WO2007092340A2 (en) * 2006-02-02 2007-08-16 H.B. Fuller Licensing & Financing, Inc. Mortuary articles including hot melt superabsorbent polymer composition, and methods of using and methods of making the same
WO2007092340A3 (en) * 2006-02-02 2008-02-07 Fuller H B Licensing Financ Mortuary articles including hot melt superabsorbent polymer composition, and methods of using and methods of making the same
JP2007222558A (en) * 2006-02-27 2007-09-06 Risa Nishihara System for preventing body liquid from leaking from dead body
JP2007223996A (en) * 2006-02-27 2007-09-06 Risa Nishihara Apparatus for sealing throat part of dead body
WO2007108538A1 (en) * 2006-03-23 2007-09-27 Axis International Co., Ltd. Corpse treatment device
WO2007108536A1 (en) * 2006-03-23 2007-09-27 Axis International Co., Ltd. Body fluid leakage preventive for dead body and dead body treating equipment using the same
JP5368972B2 (en) * 2007-04-09 2013-12-18 梨沙 西原 Container and supply pipe
WO2008129618A1 (en) * 2007-04-09 2008-10-30 Risa Nishihara Structure of connecting container to feeding pipe, container and feeding pipe
WO2008126412A1 (en) 2007-04-09 2008-10-23 Risa Nishihara Container and supply pipe connecting structure, container, and supply pipe
KR101467596B1 (en) * 2007-04-09 2014-12-04 리사 니시하라 Container and supply pipe connecting structure, container, and supply pipe
JP2009179581A (en) * 2008-01-30 2009-08-13 Model Create:Kk Agent for preventing body fluid leakage for corpse and apparatus for preventing and treating body fluid leakage
KR101061369B1 (en) 2011-02-14 2011-09-01 남승현 Leakage of fluid from the body to manufacture blockers and prepared by the preparation method leaking of fluid from the body-blockers
WO2012129565A1 (en) * 2011-03-24 2012-09-27 Greenblendz, Inc. Improved tissue preservation fluid
JP2012224614A (en) * 2011-04-08 2012-11-15 Sumitomo Seika Chem Co Ltd Body fluid leakage inhibitor
WO2012137510A1 (en) * 2011-04-08 2012-10-11 Nishihara Risa Fluid leakage inhibitor
KR101384762B1 (en) * 2012-08-08 2014-04-14 남승현 Filter manufacturing method for preventing leakage of fluid from the body and a preparation method for preventing leakage of fluid from the body produced by the filter

Also Published As

Publication number Publication date
JP3586207B2 (en) 2004-11-10

Similar Documents

Publication Publication Date Title
JP3586207B2 (en) Jelly-like body fluid leakage prevention material and body fluid leakage prevention method using the same
US5007897A (en) Drug delivery catheter
JP4029106B2 (en) Body fluid leakage preventing agent for corpse and body treatment apparatus using the same
JP4081498B2 (en) Body fluid leakage prevention agent
JPWO2004093540A1 (en) Body fluid leakage prevention device
AU2005244685B8 (en) Corpse body cavity blocking device and corpse treatment device
JP4623796B2 (en) Body fluid leakage prevention method
JP2007254350A (en) Apparatus for treating corpse
JP2001288002A5 (en)
JP2007099669A (en) Material for preventing leakage of body fluid from dead body
JP4927416B2 (en) Body throat sealing device
JP5149504B2 (en) Body treatment device
JP2007182445A (en) Apparatus for preventing leakage of humor from dead body
JP5119408B2 (en) Insertion tube for injection of body fluid leakage preventive agent for corpse and corpse treatment apparatus using the same
JP4822873B2 (en) Body fluid leakage prevention device for corpses
JP4902865B2 (en) Body fluid leakage prevention method and body fluid leakage prevention device
JP5064366B2 (en) Body fluid leakage prevention method and body fluid leakage prevention device
JP3898214B2 (en) Body fluid leakage prevention method
JP4602348B2 (en) Body cavity sealing member
JP2008255025A (en) Apparatus for treatment of dead body
JP2007091765A (en) Method for preventing body fluid leakage and device for preventing body fluid leakage
JP6721257B1 (en) Insertion tube for injecting body fluid leakage preventive agent
JP5013837B2 (en) Body treatment device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040220

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20040220

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20040405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A132

Effective date: 20040413

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040610

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040713

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040805

R150 Certificate of patent or registration of utility model

Ref document number: 3586207

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S201 Request for registration of exclusive licence

Free format text: JAPANESE INTERMEDIATE CODE: R314201

S201 Request for registration of exclusive licence

Free format text: JAPANESE INTERMEDIATE CODE: R314201

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

S201 Request for registration of exclusive licence

Free format text: JAPANESE INTERMEDIATE CODE: R314201

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100813

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100813

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100813

Year of fee payment: 6

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R314533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100813

Year of fee payment: 6

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130813

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term